<?xml version="1.0" encoding="iso-8859-1" standalone="no"?>
<!DOCTYPE GmsArticle SYSTEM "http://www.egms.de/dtd/2.0.34/GmsArticle.dtd">
<GmsArticle xmlns:xlink="http://www.w3.org/1999/xlink">
  <MetaData>
    <Identifier>25dkou109</Identifier>
    <IdentifierDoi>10.3205/25dkou109</IdentifierDoi>
    <IdentifierUrn>urn:nbn:de:0183-25dkou1099</IdentifierUrn>
    <ArticleType>Meeting Abstract</ArticleType>
    <TitleGroup>
      <Title language="en">The regulatory functions of tetraspanin CD9 in myoblast fusion</Title>
    </TitleGroup>
    <CreatorList>
      <Creator>
        <PersonNames>
          <Lastname>Wittig</Lastname>
          <LastnameHeading>Wittig</LastnameHeading>
          <Firstname>Frances</Firstname>
          <Initials>F</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Universit&#228;tsmedizin G&#246;ttingen, Klinik f&#252;r Unfallchirurgie, Orthop&#228;die und Plastische Chirurgie, G&#246;ttingen, Deutschland</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="yes">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>B&#246;ker</Lastname>
          <LastnameHeading>B&#246;ker</LastnameHeading>
          <Firstname>Kai O.</Firstname>
          <Initials>KO</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Universit&#228;tsmedizin G&#246;ttingen, Klinik f&#252;r Unfallchirurgie, Orthop&#228;die und Plastische Chirurgie, G&#246;ttingen, Deutschland</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>von Sa&#223;</Lastname>
          <LastnameHeading>von Sa&#223;</LastnameHeading>
          <Firstname>Leonie</Firstname>
          <Initials>L</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Universit&#228;tsmedizin G&#246;ttingen, Klinik f&#252;r Unfallchirurgie, Orthop&#228;die und Plastische Chirurgie, G&#246;ttingen, Deutschland</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Lehmann</Lastname>
          <LastnameHeading>Lehmann</LastnameHeading>
          <Firstname>Wolfgang</Firstname>
          <Initials>W</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Universit&#228;tsmedizin G&#246;ttingen, Klinik f&#252;r Unfallchirurgie, Orthop&#228;die und Plastische Chirurgie, G&#246;ttingen, Deutschland</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Schilling</Lastname>
          <LastnameHeading>Schilling</LastnameHeading>
          <Firstname>Arndt</Firstname>
          <Initials>A</Initials>
        </PersonNames>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
    </CreatorList>
    <PublisherList>
      <Publisher>
        <Corporation>
          <Corporatename>German Medical Science GMS Publishing House</Corporatename>
        </Corporation>
        <Address>D&#252;sseldorf</Address>
      </Publisher>
    </PublisherList>
    <SubjectGroup>
      <SubjectheadingDDB>610</SubjectheadingDDB>
    </SubjectGroup>
    <DatePublishedList>
      <DatePublished>20251031</DatePublished>
    </DatePublishedList>
    <Language>engl</Language>
    <License license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
      <AltText language="en">This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License.</AltText>
      <AltText language="de">Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung).</AltText>
    </License>
    <SourceGroup>
      <Meeting>
        <MeetingId>M0634</MeetingId>
        <MeetingSequence>109</MeetingSequence>
        <MeetingCorporation>Deutsche Gesellschaft f&#252;r Orthop&#228;die und Unfallchirurgie</MeetingCorporation>
        <MeetingCorporation>Deutsche Gesellschaft f&#252;r Orthop&#228;die und Orthop&#228;dische Chirurgie</MeetingCorporation>
        <MeetingCorporation>Deutsche Gesellschaft f&#252;r Unfallchirurgie</MeetingCorporation>
        <MeetingCorporation>Berufsverband f&#252;r Orthop&#228;die und Unfallchirurgie</MeetingCorporation>
        <MeetingName></MeetingName>
        <MeetingTitle>Deutscher Kongress f&#252;r Orthop&#228;die und Unfallchirurgie (DKOU 2025)</MeetingTitle>
        <MeetingSession>Poster &#124; Grundlagenforschung 2</MeetingSession>
        <MeetingCity>Berlin</MeetingCity>
        <MeetingDate>
          <DateFrom>20251028</DateFrom>
          <DateTo>20251031</DateTo>
        </MeetingDate>
      </Meeting>
    </SourceGroup>
    <ArticleNo>AB20-4434</ArticleNo>
  </MetaData>
  <OrigData>
    <TextBlock name="Text" linked="yes">
      <MainHeadline>Text</MainHeadline><Pgraph><Mark1>Objectives and questions: </Mark1>Skeletal muscles provide stability and enable movement. During development, mononucleated myoblasts differentiate into multinucleated myotubes, a process regulated by myogenic regulatory factors <TextLink reference="1"></TextLink>. Myotubes, which are elongated structures containing multiple nuclei <TextLink reference="1"></TextLink>, serve as precursors to mature muscle fibres. The transmembrane protein tetraspanin CD9 is present on the cell surface and contributes to cell motility, fusion and adhesion <TextLink reference="2"></TextLink>. A deeper understanding of the mechanisms of myogenesis and syncytia formation could aid the development of therapies for skeletal muscle diseases such as sarcopenia.</Pgraph><Pgraph><Mark1>Material and methods: </Mark1>Two model systems were used for analyzing the effect of CD9 on mononucear myoblast differentiation into multinuclear myotubes: C2C12 murine myoblasts and human skeletal muscle myoblasts. In these mode systems stable CD9 overexpression using a lentiviral vector system and a transient CD9 knockdown using siRNA were applied. To demonstrate overexpression, tetraspanin CD9 was tagged with green fluorescent protein. The morphology of the myotubes after differentiation was analyzed using DAPI immunostaining and myosin heavy chain immunostaining. In addition, qPCR and Western blot analysis were used to measure expression levels of CD9 and regulatory factors of differentiation.</Pgraph><Pgraph><Mark1>Results: </Mark1>Murine and human myoblasts differentiated under low serum conditions (1&#37; or 2&#37; horse serum) to multinuclear elongated myotubes. C2C12 murine myoblasts were successfully modified using a lentiviral approach to overexpress human tetraspanin CD9. In murine myoblasts, siRNA-mediated knockdown resulted in significantly lower relative gene expression of CD9. In experiments using C2C12, siRNA-mediated downregulation of CD9 resulted in smaller myotubes.</Pgraph><Pgraph><Mark1>Discussion and conclusions: </Mark1>C2C12 murine myoblasts and human myoblasts differentiated under low serum conditions to multinuclear myotubes. Subsequent fluorescence microscopy demonstrated the overexpression of CD9 in murine myoblasts due to the presence of the green fluorescent protein (GFP). Knockdown of CD9 in murine myoblasts leads into smaller multinuclear myotubes. Further studies will assess the effects on myoblast differentiation and functional contractility of myotubes under both overexpression and knockdown conditions in both model systems. The role of CD9 in myogenesis may provide new insights into the development of therapeutic strategies for musculoskeletal disorders.</Pgraph></TextBlock>
    <References linked="yes">
      <Reference refNo="1">
        <RefAuthor>Gellhaus B</RefAuthor>
        <RefAuthor>B&#246;ker KO</RefAuthor>
        <RefAuthor>Gsaenger M</RefAuthor>
        <RefAuthor>Rodenwaldt E</RefAuthor>
        <RefAuthor>H&#252;ser MA</RefAuthor>
        <RefAuthor>Schilling AF</RefAuthor>
        <RefAuthor>Saul D</RefAuthor>
        <RefTitle>Foxo3 Knockdown Mediates Decline of Myod1 and Myog Reducing Myoblast Conversion to Myotubes</RefTitle>
        <RefYear>2023</RefYear>
        <RefJournal>Cells</RefJournal>
        <RefPage>2167</RefPage>
        <RefTotal>Gellhaus B, B&#246;ker KO, Gsaenger M, Rodenwaldt E, H&#252;ser MA, Schilling AF, Saul D. Foxo3 Knockdown Mediates Decline of Myod1 and Myog Reducing Myoblast Conversion to Myotubes. Cells. 2023 Aug 29;12(17):2167. DOI: 10.3390&#47;cells12172167</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3390&#47;cells12172167</RefLink>
      </Reference>
      <Reference refNo="2">
        <RefAuthor>B&#246;ker KO</RefAuthor>
        <RefAuthor>Lemus-Diaz N</RefAuthor>
        <RefAuthor>Rinaldi Ferreira R</RefAuthor>
        <RefAuthor>Schiller L</RefAuthor>
        <RefAuthor>Schneider S</RefAuthor>
        <RefAuthor>Gruber J</RefAuthor>
        <RefTitle>The Impact of the CD9 Tetraspanin on Lentivirus Infectivity and Exosome Secretion</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>Mol Ther</RefJournal>
        <RefPage>634-47</RefPage>
        <RefTotal>B&#246;ker KO, Lemus-Diaz N, Rinaldi Ferreira R, Schiller L, Schneider S, Gruber J. The Impact of the CD9 Tetraspanin on Lentivirus Infectivity and Exosome Secretion. Mol Ther. 2018 Feb 7;26(2):634-47. DOI: 10.1016&#47;j.ymthe.2017.11.008</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.ymthe.2017.11.008</RefLink>
      </Reference>
    </References>
    <Media>
      <Tables>
        <NoOfTables>0</NoOfTables>
      </Tables>
      <Figures>
        <NoOfPictures>0</NoOfPictures>
      </Figures>
      <InlineFigures>
        <NoOfPictures>0</NoOfPictures>
      </InlineFigures>
      <Attachments>
        <NoOfAttachments>0</NoOfAttachments>
      </Attachments>
    </Media>
  </OrigData>
</GmsArticle>